No definition available.
Balanced rearrangements and structural markers, not elsewhere classified
Q17_BALANC_REARR_STRUCTURAL_MARKERS_NOT_ELSEW_CLASSIFIED
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
137 |
4. Check minimum number of eventsNone |
137 |
5. Include endpointsNone |
137 |
6. Filter based on genotype QC (FinnGen only) |
137 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CHROMOSOMAL_ABNORMALITI_NOT_ELSEW_CLASSIFIED
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q9
- Name in latin
- Translocationes aequatae et signacula structuralia sine effectu ad phaenotypum non alibi classificata
Similar endpoints
↥List of similar endpoints to
Balanced rearrangements and structural markers, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Chromosomal abnormalities, not elsewhere classified
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1147 | 633 | 509 |
| Only index persons | 1063 | 592 | 471 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.01 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 27.61 | 28.64 | 26.27 |
| Only index persons | 28.42 | 28.93 | 27.79 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 137 | 96 | 41 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | 31.16 | 29.02 | 36.19 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 123
- Matched controls
- 1229
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q95.0
ICD-10 Finland
Balanced translocation and insertion in normal individual
+∞
104.6
85
*
Z31.5
ICD-10 Finland
Genetic counselling
69.2
70.4
81
33
O35.1
ICD-10 Finland
Maternal care for (suspected) chromosomal abnormality in fetus
29.5
15.2
20
8
Q95.1
ICD-10 Finland
Chromosome inversion in normal individual
+∞
14.9
14
*
N96
ICD-10 Finland
Habitual aborter
156.6
13.7
14
*
Q95.8
ICD-10 Finland
Other balanced rearrangements and structural markers
+∞
10.6
10
*
Z82.7
ICD-10 Finland
Family history of congenital malformations, deformations and chromosomal abnormalities
96.4
8.5
9
*
Q95.2
ICD-10 Finland
Balanced autosomal rearrangement in abnormal individual
+∞
8.4
8
*
MAA10
NOMESCO Finland
Biopsy of chorionic villus
42.5
6.8
8
*
MA4AT
NOMESCO Finland
Chorion biopsy with ultrasound guidance
28.3
6.3
8
*
N46
ICD-10 Finland
Male infertility
28.3
6.3
8
*
MAA00
NOMESCO Finland
Amniocentesis
9.4
6.2
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40765089) Chromosome analysis panel - Blood by G-banded
20
9
25.69
14.71
1.0
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
27
5.66
7.13
1.4
1.3
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
6
0
+∞
6.29
1.3
0.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
17
48
3.90
5.52
1.8
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
25
113
2.48
3.69
1.6
1.6
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
10
32
3.29
2.70
1.9
1.6
nmol/l
0.5
0.5
—
10
27
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
23
116
2.18
2.65
1.1
1.3
iu/ml
57.5
121.2
—
6
46
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
8
23
3.63
2.31
1.0
1.3
—
8.6
—
0
10
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
19
3.82
2.18
2.7
2.8
e9/l
4.1
4.1
—
7
19
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
19
3.82
2.18
2.7
3.1
%
57.6
55.6
—
7
19
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
52
369
1.66
2.08
2.2
1.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
15
4.13
2.06
1.0
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
64
2.32
2.02
1.1
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
32
202
1.76
1.94
1.8
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
65
495
1.60
1.93
3.7
4.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
18
95
2.03
1.86
1.6
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
20
111
1.94
1.80
1.2
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
149
0.38
1.77
1.5
1.7
—
—
—
0
0
(4268621)
6
18
3.44
1.76
2.0
2.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
58
444
1.53
1.62
2.3
2.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
16
86
1.97
1.58
1.8
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
32
217
1.62
1.49
1.7
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
38
2.46
1.49
1.7
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
21
127
1.77
1.47
3.0
2.2
u/l
36934.2
4494.9
—
9
52
(40761511) CBC panel - Blood by Automated count
128
1195
2.08
1.41
9.1
9.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
40
0.00
1.35
0.0
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
14
77
1.91
1.31
1.6
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
44
332
1.48
1.27
4.8
6.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
25
2.46
1.26
1.8
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
19
2.69
1.22
1.8
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
97
854
1.47
1.21
4.1
4.0
pmol/l
14.8
14.3
1.04
88
796
(3000991) Gas panel - Venous blood
12
65
1.93
1.17
15.9
15.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
20
2.55
1.16
1.2
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
21
138
1.62
1.11
1.5
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
14
82
1.79
1.10
2.9
3.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
32
234
1.48
1.07
1.9
2.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
112
1025
1.51
1.04
4.6
4.4
mu/l
1.7
1.8
0.20
101
969
(4306422)
5
22
2.32
1.04
1.2
1.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
45
359
1.38
0.94
7.3
8.1
mmol/l
1.2
1.2
0.08
38
332
(3002032) Base excess in Venous blood by calculation
13
79
1.71
0.92
3.8
5.7
mmol/l
1.5
1.8
0.13
13
63
(36660697) Celiac disease serology panel - Serum
19
129
1.55
0.89
1.3
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
12
72
1.73
0.88
2.2
3.1
g/l
0.2
0.2
0.40
12
67
(3004588) Protein electrophoresis panel - Serum or Plasma
6
31
1.98
0.85
1.2
2.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
37
290
1.38
0.85
2.8
6.4
inr
1.0
1.1
1.25
11
92
(3021447) Carbon dioxide [Partial pressure] in Venous blood
13
81
1.67
0.85
3.9
5.6
kpa
6.0
5.9
0.12
13
81
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
46
1.78
0.84
1.1
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
48
395
1.33
0.81
1.9
1.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
28
211
1.41
0.80
2.1
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
33
1.85
0.80
7.5
33.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
0
25
0.00
0.80
0.0
1.2
—
1.1
—
0
19
(3044640) Blood type and Crossmatch panel - Blood
39
312
1.35
0.79
1.8
2.3
—
—
—
0
0
(3012544) pH of Venous blood
13
83
1.63
0.78
3.9
5.8
—
—
—
0
0
(4010399)
10
59
1.75
0.78
1.2
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
40
323
1.34
0.76
1.9
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
25
2.04
0.73
2.6
2.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
49
410
1.30
0.73
1.9
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
85
1.58
0.72
1.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
26
1.96
0.71
1.0
1.0
—
—
—
0
0
(3036489) Thrombin time
8
49
1.67
0.63
2.1
4.1
s
20.9
20.8
—
8
42
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
20
0.00
0.61
0.0
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
8
52
1.57
0.60
2.6
5.5
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
0
22
0.00
0.60
0.0
4.9
—
1.4
—
0
22
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
53
1.54
0.59
1.1
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
36
1.70
0.57
1.0
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
22
170
1.35
0.56
1.9
1.7
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
6
38
1.60
0.55
3.7
4.0
g/l
138.3
131.3
—
6
38
(3001019) Free T4 and TSH panel - Serum or Plasma
6
98
0.59
0.54
2.2
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
119
1137
1.35
0.52
11.2
10.7
mg/l
19.5
20.2
0.09
85
835
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
46
398
1.23
0.50
7.3
8.1
mmol/l
1.2
1.2
0.24
35
342
(3045414) Leukocytes [Presence] in Urine
7
45
1.58
0.50
1.6
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
49
1.45
0.46
1.4
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
33
278
1.25
0.46
3.1
2.5
e6/l
0.2
0.3
0.57
28
212
(3024354) Oxygen [Partial pressure] in Venous blood
10
69
1.48
0.45
4.3
5.8
kpa
5.1
4.7
—
10
69
(3022145) Colonoscopy Study observation
13
95
1.41
0.45
1.0
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
20
158
1.31
0.45
2.7
3.3
ng/l
733.6
380.8
—
8
88
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
12
161
0.72
0.44
1.0
1.6
pmol/l
385.6
437.7
0.51
12
152
(3002582) Erythrocytes [#/volume] in Urine
36
308
1.23
0.44
3.0
2.6
e6/l
24.8
246.0
0.55
30
241
(3018095) Leukocytes [#/volume] in Urine
43
375
1.21
0.43
3.4
3.0
e6/l
13.9
42.5
1.40
32
255
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
8
56
1.45
0.43
1.1
1.6
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
5
31
1.64
0.43
4.2
3.8
%
1.0
1.5
—
5
31
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
32
1.58
0.42
1.2
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
66
601
1.19
0.42
2.7
2.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
33
1.53
0.42
1.2
1.6
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
15
0.00
0.41
0.0
2.4
—
7.4
—
0
15
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
0
16
0.00
0.41
0.0
2.4
—
613.2
—
0
11
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
16
0.00
0.41
0.0
2.3
—
1.2
—
0
16
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
13.2
—
728.4
—
0
16
(3011412) CD3 cells [#/volume] in Blood
0
16
0.00
0.41
0.0
2.4
—
1.5
—
0
5
(3023183) Ammonium ion [Moles/volume] in Plasma
0
16
0.00
0.41
0.0
6.3
—
46.7
—
0
11
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
15.0
—
1278.3
—
0
16
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
0
16
0.00
0.41
0.0
2.4
—
0.2
—
0
11
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
60
1.35
0.41
1.8
2.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
8
60
1.35
0.41
7.3
8.5
mmol/l
27.3
24.9
—
8
60
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
34
1.49
0.41
1.2
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
56
504
1.19
0.40
7.3
8.0
e9/l
0.0
0.0
0.50
45
410
(3019225) pH of Specimen
10
71
1.44
0.40
2.0
5.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.6
—
2.8
—
0
13
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
49
546
0.84
0.40
4.7
3.1
estimate
0.0
0.0
0.00
13
107
(3026008) Bacteria identified in Urine by Culture
34
292
1.22
0.40
3.9
2.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
2.9
—
193.9
—
0
19
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
36
1.40
0.38
1.2
1.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
49
542
0.85
0.36
6.4
4.2
estimate
0.0
0.0
0.50
12
113
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
10
133
0.73
0.35
1.7
2.4
mmol/l
2.5
2.4
—
10
115
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
100
1.33
0.35
1.6
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
49
540
0.86
0.34
4.7
3.0
estimate
0.0
0.0
0.00
12
108
(3037467) Urinalysis macro (dipstick) panel - Urine
83
780
1.16
0.33
4.5
3.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
29
250
1.20
0.33
1.9
2.1
mg/l
0.7
0.8
0.15
24
177
(40758558) Short blood count panel - Blood
23
270
0.82
0.32
5.5
6.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
28
242
1.20
0.31
3.3
2.9
ph
7.4
7.4
—
5
42
(3013707) Erythrocyte sedimentation rate by Westergren method
81
763
1.15
0.30
4.2
3.4
mm/h
7.8
8.6
0.29
73
711
(3029937) Albumin [Presence] in Urine by Test strip
25
289
0.83
0.30
5.1
3.1
estimate
0.0
0.0
0.50
13
107
(1761868) Lipid panel - Serum or Plasma
39
433
0.86
0.29
2.1
2.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
101
968
1.17
0.29
3.0
3.1
mmol/l
5.5
5.6
0.58
88
903
(3001122) Ferritin [Mass/volume] in Serum or Plasma
64
596
1.14
0.28
3.0
2.9
ug/l
66.1
69.5
0.11
59
564
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
26
297
0.85
0.27
1.7
1.8
pmol/l
123.0
93.8
1.20
14
161
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
13
104
1.28
0.27
2.4
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
32
284
1.17
0.27
1.6
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
11
137
0.79
0.25
1.7
1.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
96
1.27
0.25
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
96
1.27
0.25
1.4
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
6
82
0.72
0.25
5.2
2.6
g/l
10.6
9.9
—
6
73
(3007461) Platelets [#/volume] in Blood
131
1287
1.41
0.25
16.1
15.5
e9/l
260.2
258.3
0.11
125
1259
(36304419) Bacteria [Presence] in Urine
32
286
1.16
0.24
3.2
2.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
14
115
1.24
0.24
6.1
7.5
mmol/l
1.1
1.1
0.17
14
110
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
38
1.33
0.23
1.6
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
5
38
1.33
0.23
1.2
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
38
1.33
0.23
1.0
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
107
1036
1.15
0.23
4.0
4.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
14
117
1.22
0.21
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
14
117
1.22
0.21
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
14
117
1.22
0.21
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
14
117
1.22
0.21
1.5
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.0
—
18.8
—
0
11
(40768800) Prostate Pathology biopsy report
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
11
0.00
0.21
0.0
2.4
—
106.4
—
0
11
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
11
0.00
0.21
0.0
2.4
—
4.1
—
0
11
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
0
10
0.00
0.21
0.0
3.0
—
67.0
—
0
10
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
0
10
0.00
0.21
0.0
2.8
—
7.8
—
0
10
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
0
10
0.00
0.21
0.0
2.8
—
23.1
—
0
10
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
36
328
1.13
0.21
1.6
1.4
u/ml
2.8
1.2
—
10
78
(3006245) CD3-CD19+ cells/100 cells in Blood
0
12
0.00
0.21
0.0
3.6
—
17.4
—
0
12
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
7.3
—
0.6
—
0
12
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.6
—
0.8
—
0
12
(3041096) Erythrocytes [Presence] in Urine by Automated
31
342
0.88
0.21
2.9
2.3
—
—
—
0
0
(44806118)
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
(44790048)
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(44790047)
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
13
0.00
0.21
0.0
2.4
—
845.6
—
0
7
(44790049)
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013512) EKG study
18
206
0.85
0.19
2.5
2.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
19
166
1.17
0.19
2.0
2.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
114
1113
1.14
0.19
13.4
11.6
%
40.3
40.3
0.06
103
941
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
7
58
1.22
0.18
4.0
6.1
mmol/l
1.3
0.8
—
7
47
(3019198) Lymphocytes [#/volume] in Blood
61
578
1.10
0.18
6.8
5.8
e9/l
2.1
2.0
0.41
54
523
(3000494) Fungus identified in Specimen by Culture
13
110
1.20
0.18
1.5
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
5
66
0.75
0.17
3.2
1.8
g/l
1.1
1.2
—
5
60
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
70
1.15
0.16
1.5
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
40
428
0.91
0.16
4.7
2.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
77
0.77
0.16
4.5
5.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
131
1291
1.34
0.16
16.1
15.6
e9/l
6.8
6.8
0.12
124
1257
(3026361) Erythrocytes [#/volume] in Blood
131
1290
1.35
0.16
16.1
15.5
e12/l
4.5
4.5
0.50
124
1259
(3023511) Choriogonadotropin [Units/volume] in Urine
9
79
1.15
0.15
2.1
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
109
1065
1.11
0.15
10.3
11.1
mmol/l
139.4
139.5
0.27
102
1031
(3013826) Glucose [Moles/volume] in Serum or Plasma
54
568
0.92
0.15
5.8
5.8
mmol/l
5.9
6.4
1.03
47
502
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
8
95
0.83
0.14
1.3
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
8
95
0.83
0.14
1.3
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
57
545
1.08
0.13
7.1
5.8
e9/l
0.6
0.5
1.04
48
481
(3006315) Basophils [#/volume] in Blood
57
545
1.08
0.13
7.2
5.8
e9/l
0.0
0.0
0.20
48
484
(40761536) Microorganisms panel - Urine sediment
12
104
1.17
0.13
5.2
2.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
17
189
0.89
0.13
1.2
1.2
u/ml
1.2
7.6
—
6
74
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
88
856
1.08
0.12
3.4
4.1
mmol/mol
35.7
38.1
1.90
78
819
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
41
388
1.08
0.12
1.8
1.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
124
1.14
0.12
1.8
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
22
239
0.91
0.11
1.8
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
21
228
0.91
0.11
6.2
3.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
62
642
0.94
0.10
6.8
8.8
e9/l
4.1
4.1
0.01
52
559
(3023103) Potassium [Moles/volume] in Serum or Plasma
109
1071
1.09
0.10
10.5
11.1
mmol/l
3.9
3.9
0.19
102
1033
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
117
1153
1.10
0.10
7.9
8.2
u/l
26.0
25.6
0.05
111
1117
(3000330) Specific gravity of Urine by Test strip
5
44
1.14
0.10
2.0
2.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
36
341
1.08
0.10
4.0
2.9
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
5
45
1.12
0.10
2.8
5.6
mmol/l
25.4
24.5
—
5
45
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
16
145
1.12
0.10
2.4
2.4
e6/l
13.4
3.5
0.72
11
71
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
101
993
1.07
0.08
8.9
8.5
ml/min/173m2
97.3
96.3
0.19
76
789
(3048689) Calprotectin [Mass/mass] in Stool
19
176
1.09
0.08
2.1
2.1
ug/g
51.5
73.8
0.39
13
125
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
34
324
1.07
0.08
1.9
2.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
12
132
0.90
0.07
1.8
2.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
20
187
1.08
0.07
3.8
4.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
34
354
0.95
0.06
2.0
2.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
24
253
0.94
0.06
1.4
1.7
mmol/l
1.4
1.4
0.04
15
229
(40760892) CBC W Ordered Manual Differential panel - Blood
28
293
0.94
0.05
6.8
4.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
58
569
1.03
0.03
7.1
6.1
e9/l
0.2
0.2
0.11
50
509
(3000492) Spirometry study
11
102
1.09
0.03
1.4
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
98
989
0.97
0.02
3.1
3.3
mmol/l
1.5
1.5
0.00
93
943
(3015736) pH of Urine
42
429
0.97
0.02
4.1
2.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
29
282
1.04
0.02
1.9
3.2
ng/l
15.5
18.9
0.18
11
134
(3007164) IgA [Mass/volume] in Serum or Plasma
31
302
1.03
0.02
1.7
1.4
g/l
1.4
2.0
1.76
14
187
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
93
1.08
0.02
1.2
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
12
113
1.07
0.02
1.2
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
16
156
1.03
0.00
2.5
2.3
e6/l
0.9
0.6
0.47
11
84
(21494755) Public health laboratory ask at order entry panel
18
176
1.03
0.00
1.1
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
100
998
1.01
0.00
3.2
3.5
mmol/l
3.0
2.8
1.80
92
949
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
99
993
0.99
0.00
3.1
3.3
mmol/l
4.8
4.6
1.05
93
950
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
18
182
0.99
0.00
1.3
1.3
iu/ml
7.6
23.9
—
7
51
(3036481) Cortisol [Moles/volume] in Serum or Plasma
12
115
1.05
0.00
1.7
1.8
nmol/l
369.1
389.7
0.18
12
105
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
5
0.00
0.00
0.0
3.2
—
16.0
—
0
5
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
7
0.00
0.00
0.0
1.4
—
0.3
—
0
7
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(4281824)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
94
940
1.00
0.00
2.8
3.1
mmol/l
1.2
1.2
0.32
88
891
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
9.0
—
0
5
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
2.1
—
0
6
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
6
0.00
0.00
0.0
1.0
—
33.0
—
0
6
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
12
120
1.00
0.00
3.2
1.6
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
6
63
0.95
0.00
1.7
2.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
8
81
0.99
0.00
2.1
1.2
u/ml
257.9
95.0
—
8
70
(3028433) Virus identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
4.4
—
27.3
—
0
9
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_BALANC_REARR_STRUCTURAL_MARKERS_NOT_ELSEW_CLASSIFIED and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_BALANC_REARR_STRUCTURAL_MARKERS_NOT_ELSEW_CLASSIFIED.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_BALANC_REARR_STRUCTURAL_MARKERS_NOT_ELSEW_CLASSIFIED – Balanced rearrangements and structural markers, not elsewhere classified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data